• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

30
16
10
9
8

COUNTRY

7
4
3
3
2

CATEGORIES

  • 34
  • 16
  • 14
  • 12
  • 11
  • 11
  • 8
  • 5
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

37
42
44
98

PUBLISHED

23
27
37
98

PRODUCT TYPE

57
39
2

Search "Molecular Epidemiology of Chronic Diseases - DUPLICATE" returned 98 results.

PRODUCT TITLE

Molecular Epidemiology of Chronic Diseases

"I think this is an excellent book–I recommend it to anyone involved in molecular epidemiology... The 26 chapters are written by topic specialists, in an explanatory, east to read style." –BTS Newsletter,...

April 2008
Animal Biotechnology - Technologies, Markets and Companies Animal Biotechnology - Technologies, Markets and Companies - Product Thumbnail Image

Animal Biotechnology - Technologies, Markets and Companies

This report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production. Knowledge of animal genetics is important...

November 2014
FROM
Molecular Diagnostics - Technologies, Markets and Companies Molecular Diagnostics - Technologies, Markets and Companies - Product Thumbnail Image

Molecular Diagnostics - Technologies, Markets and Companies

This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological...

November 2014
FROM
Pain Therapeutics - Drugs, Markets and Companies Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

This report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic...

November 2014
FROM
Future Horizons in the US Molecular Diagnostics Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications Future Horizons in the US Molecular Diagnostics Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications - Product Thumbnail Image Special Offer Sale Banner

Future Horizons in the US Molecular Diagnostics Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications

This report presents a comprehensive analysis of the US molecular diagnostics market, including:Major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic,...

August 2012
FROM
Future Horizons and Growth Strategies in the US Molecular Diagnostics Market 2014: Supplier Shares and Country Forecasts Future Horizons and Growth Strategies in the US Molecular Diagnostics Market 2014: Supplier Shares and Country Forecasts - Product Thumbnail Image Special Offer Sale Banner

Future Horizons and Growth Strategies in the US Molecular Diagnostics Market 2014: Supplier Shares and Country Forecasts

This new 880-page report from the author contains 37 tables, and presents a comprehensive analysis of the US molecular diagnostics market, including: Major issues pertaining to the US molecular diagnostics...

August 2014
FROM
Personalized Medicine - Scientific and Commercial Aspects Personalized Medicine - Scientific and Commercial Aspects - Product Thumbnail Image

Personalized Medicine - Scientific and Commercial Aspects

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her...

November 2014
FROM
Biomarkers - Technologies, Markets and Companies Biomarkers - Technologies, Markets and Companies - Product Thumbnail Image

Biomarkers - Technologies, Markets and Companies

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological...

November 2014
FROM
Alzheimer Disease - New Drugs, Markets and Companies Alzheimer Disease - New Drugs, Markets and Companies - Product Thumbnail Image

Alzheimer Disease - New Drugs, Markets and Companies

Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable...

November 2014
FROM
Gene Therapy - Technologies, Markets and Companies Gene Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

November 2014
FROM

Neurobiology of Psychiatric Disorders, Vol 106. Handbook of Clinical Neurology

This new volume in the Handbook of Clinical Neurology presents a comprehensive review of the fundamental science and clinical treatment of psychiatric disorders. Advances in neuroscience have allowed...

June 2012
Future Horizons in the Global Molecular Diagnostics Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Country Future Horizons in the Global Molecular Diagnostics Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Country - Product Thumbnail Image Special Offer Sale Banner

Future Horizons in the Global Molecular Diagnostics Market: Supplier Shares and Sales Forecasts for 35 Tests and Applications by Country

This comprehensive seven-country, 1,050-page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market...

August 2012
FROM

Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022

Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Tasigna (Chronic Myeloid Leukemia) - Forecast...

May 2013
FROM
Antiviral Therapeutics - Technologies, Markets and Companies Antiviral Therapeutics - Technologies, Markets and Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets and Companies

This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The introduction starts with a practical...

November 2014
FROM
Cardiovascular Drug Delivery - Technologies, Markets and Companies Cardiovascular Drug Delivery - Technologies, Markets and Companies - Product Thumbnail Image

Cardiovascular Drug Delivery - Technologies, Markets and Companies

Drug delivery to the cardiovascular system is different from delivery to other systems because of the anatomy and physiology of the vascular system; it supplies blood and nutrients to all organs of...

November 2014
FROM

Textbook of Psychiatric Epidemiology. 3rd Edition

The new edition of this critically praised textbook continues to provide the most comprehensive overview of the concepts, methods, and research advances in the field; particularly the application of...

April 2011

PharmaPoint: Chronic Myeloid Leukemia (CML) - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Chronic Myeloid Leukemia (CML) -...

April 2013
FROM

PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Chronic Myeloid Leukemia...

April 2013
FROM

PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Chronic Myeloid Leukemia...

April 2013
FROM

PharmaPoint: Chronic Myeloid Leukemia (CML) - Germany Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - Germany Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Chronic Myeloid Leukemia (CML)...

April 2013
FROM
Loading Indicator

Our Clients

Our clients' logos